摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 4'-<(4'-chloro-2'-pyridinyl)amino>-6-methyl-2-oxocyclohex-3-en-1-oate | 149221-14-7

中文名称
——
中文别名
——
英文名称
methyl 4'-<(4'-chloro-2'-pyridinyl)amino>-6-methyl-2-oxocyclohex-3-en-1-oate
英文别名
methyl 4-[(4'-chloro-2'-pyridinyl)amino]-6-methyl-2-oxo-3-cyclohexen-1-carboxylate;methyl 4-[(5-chloro-2-pyridyl)amino]-6-methyl-2-oxo-3-cyclohexene-1-carboxylate;Methyl 4-((5-chloro-2-pyridinyl)amino)-6-methyl-2-oxo-3-cyclohexene-1-carboxylate;methyl 4-[(5-chloropyridin-2-yl)amino]-6-methyl-2-oxocyclohex-3-ene-1-carboxylate
methyl 4'-<(4'-chloro-2'-pyridinyl)amino>-6-methyl-2-oxocyclohex-3-en-1-oate化学式
CAS
149221-14-7
化学式
C14H15ClN2O3
mdl
——
分子量
294.738
InChiKey
BFAOEAQFZQPPRV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    422.5±45.0 °C(Predicted)
  • 密度:
    1.327±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    68.3
  • 氢给体数:
    1
  • 氢受体数:
    5

SDS

SDS:ab3faf0285489e6dbc1ea386246ee6a6
查看

反应信息

  • 作为产物:
    描述:
    2-氨基-5-氯吡啶甲基6-甲基-2,4-环己二酮羧酸酯 为溶剂, 反应 5.0h, 以43%的产率得到methyl 4'-<(4'-chloro-2'-pyridinyl)amino>-6-methyl-2-oxocyclohex-3-en-1-oate
    参考文献:
    名称:
    烯胺酮的合成和抗惊厥活性。2.进一步的结构活性相关性。
    摘要:
    该报告继续对4-[(对氯苯基)氨基] -6-甲基-2-氧代环己基-3-烯-1-酸酯1(ADD 196022)和甲基4-(苄基氨基)进行深入评估-6-甲基-2-氧代环己基-3-烯-1-酸酯,2个,两个有效的抗惊厥性烯胺酮。这些化合物采用杏仁核点燃模型进行评估。1和2都没有针对杏仁核点燃的癫痫发作的活性,进一步支持了角膜点燃的模型作为抗电击癫痫发作评估的确定工具,如先前报道。关于1的其他腹膜内(ip)数据显示,在100 mg / kg的24小时内有毒性。为了使毒性最小化,已经制备了几种活性类似物。在由抗癫痫药物开发(ADD)计划开发的特殊ip大鼠屏幕中,对这些新的类似物进行了评估,以防最大剂量10 mg / kg的电击惊厥(MES)和100 mg / kg的神经毒性。从该筛选中,显示出几种化合物是更安全的替代品,最引人注目的是4-[((对-溴苯基)氨基] -6-甲基-2-氧代环己基-3-en-
    DOI:
    10.1021/jm00066a003
点击查看最新优质反应信息

文献信息

  • Ultraviolet spectroscopy of anticonvulsant enaminones
    作者:I.O Edafiogho、O.A Phillips、M Abdel-Hamid、A.A.M Ali、W.C Matowe、A El-Hashim、S.B Kombian
    DOI:10.1016/s0968-0896(01)00314-5
    日期:2002.3
    The ultraviolet (UV) spectra of selected enaminones were determined in acidic, alkaline and neutral media and compared to their anticonvulsant activities. The wavelength of maximum absorption and molar absorptivity were compared with the anticonvulsant activity of the selected secondary and tertiary enaminones. and general inferences were made. The UV spectra of the enaminones had hypsochromic shifts in acidic media in comparison with neutral media. Generally, a small hypsochromic shift occurred in alkaline media when compared to the neutral solutions of the enaminones. The tertiary enaminones absorbed UV light at longer wavelength than the secondary enaminones in acidic, neutral and alkaline media. In particular, the tertiary enaminones displayed absorption at the higher end and secondary enaminones towards the lower end of the UV wavelength range 292-315 nm in aqueous media. Tertiary enaminones (30-33) which were devoid of the NH proton were found to be uniformly inactive in a mouse model of electroshock seizures, while some secondary enaminones (1, 5-8, 12. 16, 18, 20, 23-25, 28 and 29) had anticonvulsant activity. Thus the NH group of secondary enaminones is very important for anticonvulsant activity, and this agrees with an already established trend in proton NMR spectroscopy. In addition, the pares-substitution on the phenyl group in some enaminones result in higher molar absorptivity (a) values that enhance anticonvulsant activity. These results indicate that the anticonvulsant activity of enaminones is not due to electronic effect alone, but is probably due to a combination of factors including electronic and steric effects. lipophilicity, and hydrogen bonding. (C) 2002 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-